A Florida-based healthcare company just announced that its partner, Genesis Botanical Research (GBR) took in the delivery of CBD extraction equipment. MJ Biotech, Inc. (OTCPK:MJTV) said that the post-secondary extraction lines are being erected at a temporary satellite location for assembly and fine-tuning before they are moved to the Maine extraction facility.
MJ Biotech focuses on the distribution of Hemp (CBD) based Tea products. The company's focus is to pursue health/biotech and sector related companies that offer healthcare solutions ranging from cutting edge to traditional options.
Traders were massively bullish on the news as shares reached an early session high of $0.0146/share (+69.7%) following the news. This move is a strong continuation of the success this stock has had over the last few months, coming from its December 2020 low of just $0.0005/share.
